Taken together, our results indicate that JAM-A positively controls NSCLC cell proliferation by regulating expression of the cell cycle-related molecules, such as cyclin D1, CDK4, CDK6, and P-RB. Here, CDK4 is linked to non-small cell lung carcinoma.